The Adaptive designs CONSORT Extension (ACE) Statement: A checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

Abstract

Background Adaptive designs (ADs) allow pre-planned changes to an ongoing trial without compromising the validity of conclusions and it is essential to distinguish pre-planned from unplanned changes that may also occur. The reporting of ADs in randomised trials is inconsistent and needs improving. Incompletely reported AD randomised trials are difficult to reproduce and are hard to interpret and synthesise. This consequently hampers their ability to inform practice as well as future research and contributes to research waste. Better transparency and adequate reporting will enable the potential benefits of ADs to be realised. Methods This extension to the Consolidated Standards Of Reporting Trials (CONSORT) 2010 Statement was developed to enhance the reporting of randomised AD clinical trials. We developed an Adaptive designs CONSORT Extension (ACE) guideline through a two-stage Delphi process with input from multidisciplinary key stakeholders in clinical trials research in the public and private sectors from 21 countries, followed by a consensus meeting. Members of the CONSORT Group were involved during the development process. Results The paper presents the ACE checklists for AD randomised trial reports and abstracts, as well as an explanation with examples to aid the application of the guideline. The ACE checklist is comprised of seven new items, nine modified items, six unchanged items for which additional explanatory text clarifies further considerations for ADs, and 20 unchanged items not requiring further explanatory text. The ACE abstract checklist has one new item, one modified item, one unchanged item with additional explanatory text for ADs, and 15 unchanged items not requiring further explanatory text. Conclusions The intention is to enhance transparency and improve reporting of AD randomised trials to improve the interpretability of their results and reproducibility of their methods, results and inference. We also hope indirectly to facilitate the much-needed knowledge transfer of innovative trial designs to maximise their potential benefits.

Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia

“…T h e ne w e ngl a nd jou r na l o f m e dicine undergone randomization but for whom outcome data were not yet available at the time of the third interim analysis; these participants were referred to as "overrunning participants." 30 The statistical analysis plan and additional details regarding sample-size considerations for the primary outcome are provided in the protocol.…”

An adaptive design for early clinical development including interim decision for single‐arm trial with external controls or randomized trial

“…Further guidance for the practical implementation of adaptive randomization and adaptive designs in general can also be helpful for planning and conducting a trial with the proposed design as well as reporting its results. [28][29][30][31][32][33][34] We recommend setting up the trial like a randomized controlled clinical trial (double-blind if possible) with an interactive web response system (IWRS) which requires complete data for all potential confounders. Although the complex set-up is not needed for the single-arm setting, it reduces the risk of change in recruitment behavior.…”

Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19

“…We highlight the benefits provided by the flexibility of adaptive designs. Following the recent CONSORT extension for adaptive designs (Dimairo et al 2020), we define an adaptive design as "A clinical trial design that offers preplanned opportunities to use accumulating trial data to modify aspects of an ongoing trial while preserving the validity and integrity of that trial. " We provide a guide to the literature on statistical methods for such designs, briefly describing the main approaches and giving key references.…”